Merit Financial Group »

Takeda Pharmaceutical shares owned by Merit Financial Group

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $277k 18k 15.59
2025-09-30 $310k 21k 14.64
2025-06-30 $282k 18k 15.46

More positions owned by Merit Financial Group

Vanguard Index Fds Growth Etf (VUG)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Us Gwt (IUSG)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard World Mega Grwth Ind (MGK)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Vanguard World Mega Cap Val Etf (MGV)
Microsoft Corporation (MSFT)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Core Msci Emkt (IEMG)
Spdr Series Trust State Street Spd (SPTI)
Ishares Tr Eafe Value Etf (EFV)

View all positions for Merit Financial Group

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
FMR
UBS Group
Brandes Investment Partners
Toronto-Dominion Bank
BlackRock
Millennium Management
Renaissance Technologies
First Trust Advisors
Van Eck Associates Corp.
Northern Trust
Citadel Advisors
Managed Asset Portfolios

View all funds holding Takeda Pharmaceutical